TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis
The pathogenesis of paradoxical psoriasis in patients receiving anti-TNF treatments for classical psoriasis is unclear. Here, the authors show that anti-TNF drugs enhance the production of type I interferon by plasmacytoid dendritic cells, causing skin lesions that, unlike classical psoriasis, lack...
Guardado en:
Autores principales: | Curdin Conrad, Jeremy Di Domizio, Alessio Mylonas, Cyrine Belkhodja, Olivier Demaria, Alexander A. Navarini, Anne-Karine Lapointe, Lars E. French, Maxime Vernez, Michel Gilliet |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/180fc992d72e4fcbbf1d606055e86015 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
TNFα blockade overcomes resistance to anti-PD-1 in experimental melanoma
por: Florie Bertrand, et al.
Publicado: (2017) -
Paradoxical SAPHO syndrome observed during anti-TNF-α therapy for Crohn's disease
por: Amano H, et al.
Publicado: (2017) -
Hepatitis B reactivation in psoriasis patients treated with anti-TNF agents: prevention and management
por: Cannizzaro MV, et al.
Publicado: (2017) -
Takayasu’s arteritis occurring under TNF blockers in a patient with spondyloarthritis: is it an association or a paradoxical effect?
por: Amel Rezgui, et al.
Publicado: (2021) -
Role of subnetworks mediated by $$\hbox {TNF}\alpha$$ TNF α , IL-23/IL-17 and IL-15 in a network involved in the pathogenesis of psoriasis
por: Rakesh Pandey, et al.
Publicado: (2021)